切换至 "中华医学电子期刊资源库"

中华医学超声杂志(电子版) ›› 2018, Vol. 15 ›› Issue (10) : 767 -772. doi: 10.3877/cma.j.issn.1672-6448.2018.10.008

所属专题: 文献

腹部超声影像学

实时组织弹性成像联合超声造影技术在慢性乙型肝炎患者肝纤维化诊断中的应用
杜昕苓1, 张久维1, 岳民璐1, 王继华1, 杨秀华1,()   
  1. 1. 150001 哈尔滨医科大学附属第一医院腹部超声科
  • 收稿日期:2017-06-29 出版日期:2018-10-01
  • 通信作者: 杨秀华

Value of real-time tissue elastography and contrast-enhanced ultrasonography in liver fibrosis assessment in patients with chronic hepatitis B

Xinling Du1, Jiuwei Zhang1, Minlu Yue1, Jihua Wang1, Xiuhua Yang1,()   

  1. 1. Department of Abdominal ultrasound, the First Affiliated Hospital of Harbin Medical University, Harbin 150006, China
  • Received:2017-06-29 Published:2018-10-01
  • Corresponding author: Xiuhua Yang
  • About author:
    Corresponding author: Yang Xiuhua, Email:
引用本文:

杜昕苓, 张久维, 岳民璐, 王继华, 杨秀华. 实时组织弹性成像联合超声造影技术在慢性乙型肝炎患者肝纤维化诊断中的应用[J/OL]. 中华医学超声杂志(电子版), 2018, 15(10): 767-772.

Xinling Du, Jiuwei Zhang, Minlu Yue, Jihua Wang, Xiuhua Yang. Value of real-time tissue elastography and contrast-enhanced ultrasonography in liver fibrosis assessment in patients with chronic hepatitis B[J/OL]. Chinese Journal of Medical Ultrasound (Electronic Edition), 2018, 15(10): 767-772.

目的

探讨实时组织弹性成像(RTE)联合超声造影技术评估乙型肝炎肝纤维化的临床应用价值,为评价慢性乙型肝炎肝纤维化提供新的无创诊断方法。

方法

选取2016年10月至2017年5月在哈尔滨医科大学附属第一医院就诊的慢性乙型肝炎患者61例,并行肝活检,根据Scheuer标准分为5期(S0~S4),所有患者均行RTE及超声造影检查,计算肝纤维化指数(LFI)与肝肾达峰时间差(Lt-Kt)。采用方差分析比较肝纤维化各组的LFI值与Lt-Kt值,并与病理结果做相关分析。进一步两两比较采用LSD-t检验,以肝活检为"金标准"得到各组诊断受试者工作特征(ROC)曲线。

结果

LFI值S1期与S2期间比较,差异无统计学意义(P>0.05),Lt-Kt值S0期与S1期间比较,差异无统计学意义(P>0.05),LFI值S0与S1、S2、S3、S4期多重比较(t=-2.32、-3.92、-6.35、-11.58),LFI值S1与S0、S2、S3、S4期多重比较(t=2.32、-1.59、-4.15、-9.44),LFI值S2与S0、S1、S3、S4期多重比较(t=3.92、1.59、-3.31、-9.86),LFI值S3与S0、S1、S2、S4期多重比较(t=6.35、4.15、3.31、6.28),LFI值S4与S0、S1、S2、S3期多重比较(t=11.58、9.44、9.86、6.28)。Lt-Kt值S0与S1、S2、S3、S4期多重比较(t=-1.81、-4.51、-5.98、-9.58),Lt-Kt值S1与S0、S2、S3、S4期多重比较(t=1.81、-2.37、-3.94、-7.60),Lt-Kt值S2与S0、S1、S3、S4期多重比较(t=4.51、2.37、-2.12、-6.69),Lt-Kt值S3与S0、S1、S2、S4期多重比较(t=5.98、3.94、2.12、-4.37),Lt-Kt值S4与S0、S1、S3、S4期多重比较(t=9.58、7.60、6.69、4.37),差异均有统计学意义(P均<0.05)。LFI对应ROC曲线下面积分别为0.953、0.924、0.916、0.983;Lt-Kt对应ROC曲线下面积分别为0.979、0.967、0.902、0.949。二者联合后对应ROC曲线下面积分别为0.988、0.974、0.918、0.966。

结论

RTE及超声造影在乙型肝炎肝纤维化诊断中均有重要价值,超声造影在纤维化早期(S1~S2)较RTE更有优势,而RTE在纤维化中晚期(S3~S4)较超声造影更有优势,二者联合可在(S1~S3期)提高纤维化诊断的准确性。

Objective

To investigate the clinical value of real-time elastography (RTE) and contrast-enhanced ultrasound (CEUS) in the evaluation of liver fibrosis in patients with chronic hepatitis B, in order to provide a new noninvasive method for assessment of liver fibrosis in chronic hepatitis B.

Methods

Sixty-one patients with chronic hepatitis B were divided into five groups according to the pathological stage of hepatic fibrosis: S0-S4. All the patients underwent RTE and CEUS examinations. The liver fibrosis index (LFI) and liver-kidney peak time difference (Lt-Kt) were calculated and analyzed by one-way ANOVA, followed by pairwise comparisons using the LSD-t test and the SNK test. The receiver operating characteristic curves (ROCs) were plotted based on the stage of liver fibrosis and used to evaluate the diagnostic value of real-time elastography and CEUS, alone or in combination.

Results

There was no significant difference in LFI values between stages S1 and S2 and between stages S0 and S1 (P>0.05); however, a significant difference was observed in LFI values between S0 and S1, S2, S3, or S4 (t=2.32, 3.92, 6.35, 11.58), between S1 and S0, S2, S3, or S4 (t=2.32, 1.59, 4.15, 9.44), between S2 and S0, S1, S3, or S4 (t=3.92, 1.59, -3.31, -9.86), between S3 and S0, S1, S2, or S4 (t=6.35, 4.15, 3.31, 6.28), and between S4 and S0, S1, S2, or S4 (t=11.58, 9.44, 9.86, 6.28) (P<0.05 for all). A significant difference was also observed in Lt-Kt values between S0 and S1, S2, S3, or S4 (t=-1.81, -4.51, -5.98, -9.58), between S1 and S0, S2, S3, or S4 (t=1.81, -2.37, -3.94, -7.60), between S2 and S0, S1, S3, or S4 (t=4.51, 2.37, -2.12, -6.69), between S3 and S0, S1, S2, or S4 (t=5.98, 3.94, 2.12, -4.37), and between S4 and S0, S1, S3, or S4 (t=9.58, 7.60, 6.69, 4.37) (P<0.05 for all). The areas under the ROCs (AUROCs) of LFI for S1-S4 were 0.953, 0.924, 0.916, and 0.983, respectively, and the AUROCs of Lt-Kt for S1-S4 were 0.979, 0.967, 0.902, and 0.949, respectively. The AUROCs of LFI combined with Lt-Kt for S1-S4 were 0.988, 0.974, 0.918, and 0.966, respectively.

Conclusion

RTE and CEUS have important value in the diagnosis of hepatic fibrosis in chronic hepatitis B. CEUS is superior to RTE in the diagnosis of early fibrosis (S1-S2), while RTE has advantages over CEUS in the detection of middle and late fibrosis (S3-S4). The combination of the two modality can improve the accuracy of diagnosis of liver fibrosis (S1-S3).

表1 S0~S4期肝纤维化指数及达峰时间差比较
表2 RTE在S0~S4期肝纤维化分期中ROC曲线结果
表3 达峰时间差在S0~S4期肝纤维化分期中ROC曲线结果
表4 RTE与达峰时间差二者联合在S0~S4期肝纤维化期中ROC曲线结果
图4 S=4肝纤维化分期三种方法ROC曲线图
1
Kanamoto M, Shimada M, Ikegami T, et al. Real time elastography for noninvasive diagnosis of liver fibrosis [J]. J Hepatobiliary Pancreat Surg, 2009, 16(4): 463-467.
2
Mesnage R, Arno M, Costanzo M, et al. Transcriptome profile analysis reflects rat liver and kidney damage following chronic ultra-low dose Roundup exposure [J]. Environ Health, 2015, 14: 70.
3
Lurie Y, Webb M, Cytter-Kuint R, et al. Non-invasive diagnosis of liver fibrosis and cirrhosis [J]. World J Gastroenterol, 2015, 21(41): 11567-11583.
4
沈伟,郑梦琳,郭佳. RTE、FIB-4、APRI对乙型肝炎患者肝纤维化的诊断价值比较 [J]. 检验医学与临床, 2017, 14(5): 637-639.
5
刘刚,李孟天,丰锦春, 等. RTE对病毒性肝炎肝纤维化分级诊断的meta分析 [J]. 中华灾害救援医学, 2016, 4(6): 310-314.
6
Hou J, Wang G, Wang F, et al. Guideline of Prevention and Treatment for Chronic Hepatitis B (2015 Update) [J]. J Clin Transl Hepatol, 2017, 5(4): 297-318.
7
Colombo S, Buonocore M, Del Poggio A, et al. Head-to-head comparison of transient elastography (TE), real-time tissue elastography (RTE), and acoustic radiation force impulse (ARFI) imaging in the diagnosis of liver fibrosis [J]. J Gastroenterol, 2012, 47(4): 461-469.
8
Zamirian M, Sarmadi T, Aghasadeghi K, et al. Liver cirrhosis prevents atrial fibrillation:A reality or just an illusion [J]. J Cardiovasc Dis Res, 2012, 3(2): 109-112.
9
Koizumi Y, Hirooka M, Kisaka Y, et al. Liver fibrosis in patients with chronichepatitis C: noninvasive diagnosis by means of real-time tissue elastography-establishment of the method for measurement [J]. Radiology, 2011, 258(2): 610-617.
10
Fujimoto K, Kato M, Kudo M, et al. Novel image analysis method using ultrasound elastography for noninvasive evaluation of hepatic fibrosis in patients with chronic hepatitis C [J]. Oncology, 2013, 84(Suppl 1): 3-12.
11
Jeong SW. Another Face of Contrast-Enhanced Ultrasonography: A Diagnostic Tool for Cirrhosis [J]. Gut Liver, 2017, 11(1): 9-10.
12
Hong H, Li J, Jin Y, et al. Performance of real-time elastography for the staging of hepatic fibrosis: a meta-analysis [J]. PloS One, 2014, 9(12): e115702.
13
Nasr P, Hilliges A, Thorelius L, Kechagias S, Ekstedt M. Contrast-enhanced ultrasonography could be a non-invasive method for differentiating none or mild from severe fibrosis in patients with biopsy proven non-alcoholic fatty liver disease [J]. Scand J Gastroenterol, 2016, 51(9): 1126-1132.
14
Ishibashi H, Maruyama H, Takahashi M, et al. Assessment of hepatic fibrosis by analysis of the dynamic behaviour of microbubbles during contrast ultrasonography [J]. Liver Int, 2010, 30(9): 1355-1163.
15
陈敏,贾春梅. 超声造影肝实质灌注成像评价肝纤维化分期的实验研究 [J]. 中国当代医药, 2013, 20(4): 104-105.
16
王刚,刘健. 超声造影在评估肝炎肝纤维化及肝硬化中的应用价值 [J]. 中国医学创新, 2011, 8(31): 100-102.
17
陆雄,刘平. 肝纤维化过程中一个重要的病理改变-肝窦毛细血管化 [J]. 中华肝脏病杂志, 2001, 9(1): 53-54.
18
Rockey D. Hepatic blood flow regulation by stellate cells in normal and injured liver [J]. Semin Liver Dis, 2001, 21(3): 337-349.
19
Higashi T, Friedman SL, Hoshida Y. Hepatic stellate cells as key target in liver fibrosis [J]. Adv Drug Deliv Rev, 2017, 121: 27-42.
20
Iredale JP, Pellicoro A, Fallowfield JA. Liver Fibrosis: Understanding the Dynamics of Bidirectional Wound Repair to Inform the Design of Markers and Therapies [J]. Dig Dis, 2017, 35(4): 310-313.
[1] 张雨, 杨松. 世界卫生组织《慢性乙型肝炎预防、诊断、关怀及治疗指南(2024年版)》解读[J/OL]. 中华实验和临床感染病杂志(电子版), 2024, 18(03): 129-134.
[2] 陈观梅, 左璇, 廖宝林. 慢性乙型肝炎新型免疫治疗研究进展[J/OL]. 中华实验和临床感染病杂志(电子版), 2024, 18(01): 7-10.
[3] 李建美, 邓静娟, 杨倩. 两种术式联合治疗肝癌合并肝硬化门静脉高压的安全性及随访评价[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(01): 41-44.
[4] 吴方园, 孙霞, 林昌锋, 张震生. HBV相关肝硬化合并急性上消化道出血的危险因素分析[J/OL]. 中华普外科手术学杂志(电子版), 2024, 18(01): 45-47.
[5] 贺健, 张骊, 王洪海, 蒋文涛. 肝移植术后脾功能亢进转归及治疗研究进展[J/OL]. 中华移植杂志(电子版), 2024, 18(05): 310-314.
[6] 王浩源, 汪海洋, 孙建明, 陈以宽, 祁小桐, 唐博. 腹腔镜与开放修补对肝硬化腹外疝患者肝功能及凝血的影响[J/OL]. 中华疝和腹壁外科杂志(电子版), 2024, 18(06): 654-659.
[7] 蔡艺丹, 方坚, 张志强, 陈莉, 张世安, 夏磊, 阮梅, 李东良. 经颈静脉肝内门体分流术对肝硬化门脉高压患者肠道菌群及肝功能的影响[J/OL]. 中华细胞与干细胞杂志(电子版), 2024, 14(05): 285-293.
[8] 邓万玉, 陈富, 许磊波. 肝硬化与非肝硬化乙肝相关性肝癌患者术后无复发生存比较及其影响因素分析[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(05): 670-674.
[9] 刘起帆, 蒋安. 肝硬化门静脉高压症门静脉压力无创测量进展[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(03): 270-275.
[10] 张宇, 余灵祥, 赵亮, 张宁, 赵德希, 刁广浩, 杨木易, 刘佳, 李鹏, 任辉. 利伐沙班在脾切除联合贲门周围血管离断术后门静脉血栓预防中的疗效[J/OL]. 中华肝脏外科手术学电子杂志, 2024, 13(02): 195-199.
[11] 崔健, 夏青, 林云, 李光玲, 李心娜, 王位. 血小板与淋巴细胞比值、免疫球蛋白、心肌酶谱及心电图对中老年肝硬化患者病情及预后的影响[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(05): 400-406.
[12] 秦相清, 朱陈, 张海银. 构建诺模图模型预测肝硬化食管胃底静脉曲张出血的风险[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(04): 330-335.
[13] 刘燚隆, 党荣广, 艾蓉, 张凯. 肝硬化合并静脉曲张出血患者内镜治疗后再出血风险的模型建立与验证[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(04): 336-342.
[14] 戚泽雪, 赵连晖, 王广川, 张春清. 从国内专家共识推荐意见更新探讨经颈静脉肝内门体分流术的临床应用进展[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(03): 193-196.
[15] 王秀, 王义国. 益生菌联合恩替卡韦治疗乙型肝炎肝硬化临床疗效的meta分析[J/OL]. 中华消化病与影像杂志(电子版), 2024, 14(02): 164-171.
阅读次数
全文


摘要


AI


AI小编
你好!我是《中华医学电子期刊资源库》AI小编,有什么可以帮您的吗?